Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Interest Expenses: 2009-2024

Historic Interest Expenses for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to $2.2 million.

  • Cross Country Healthcare's Interest Expenses rose 109.09% to $556000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 415.51%. This contributed to the annual value of $2.2 million for FY2024, which is 7296.76% down from last year.
  • Per Cross Country Healthcare's latest filing, its Interest Expenses stood at $2.2 million for FY2024, which was down 7296.76% from $8.1 million recorded in FY2023.
  • Cross Country Healthcare's Interest Expenses' 5-year high stood at $14.4 million during FY2022, with a 5-year trough of $2.2 million in FY2024.
  • Over the past 5 years, Cross Country Healthcare's median Interest Expenses value was $6.9 million (recorded in 2021), while the average stood at $6.9 million.
  • As far as peak fluctuations go, Cross Country Healthcare's Interest Expenses surged by 13757.79% in 2021, and later crashed by 7296.76% in 2024.
  • Annual analysis of 5 years shows Cross Country Healthcare's Interest Expenses stood at $2.9 million in 2020, then soared by 137.58% to $6.9 million in 2021, then surged by 109.6% to $14.4 million in 2022, then tumbled by 43.76% to $8.1 million in 2023, then plummeted by 72.97% to $2.2 million in 2024.
  • Its last three reported values are $2.2 million in FY2024, $8.1 million for FY2023, and $14.4 million during FY2022.